SG11201810015YA - Particle for the encapsidation of a genome engineering system - Google Patents
Particle for the encapsidation of a genome engineering systemInfo
- Publication number
- SG11201810015YA SG11201810015YA SG11201810015YA SG11201810015YA SG11201810015YA SG 11201810015Y A SG11201810015Y A SG 11201810015YA SG 11201810015Y A SG11201810015Y A SG 11201810015YA SG 11201810015Y A SG11201810015Y A SG 11201810015YA SG 11201810015Y A SG11201810015Y A SG 11201810015YA
- Authority
- SG
- Singapore
- Prior art keywords
- encapsidation
- particle
- engineering system
- genome engineering
- viral rnas
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
- C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/85—Fusion polypeptide containing an RNA binding domain
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPRs]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16023—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16041—Use of virus, viral particle or viral elements as a vector
- C12N2740/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16051—Methods of production or purification of viral material
- C12N2740/16052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/18011—Details ssRNA Bacteriophages positive-sense
- C12N2795/18111—Leviviridae
- C12N2795/18122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/24—Vectors characterised by the absence of particular element, e.g. selectable marker, viral origin of replication
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/50—Vectors for producing vectors
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1654332A FR3051196B1 (fr) | 2016-05-13 | 2016-05-13 | Particule pour l'encapsidation d'un systeme d'ingenierie du genome |
| FR1660309 | 2016-10-24 | ||
| FR1752818 | 2017-03-31 | ||
| PCT/FR2017/051164 WO2017194902A2 (fr) | 2016-05-13 | 2017-05-12 | Particule pour l'encapsidation d'un système d'ingénierie du génome |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201810015YA true SG11201810015YA (en) | 2018-12-28 |
Family
ID=59070995
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201810015YA SG11201810015YA (en) | 2016-05-13 | 2017-05-12 | Particle for the encapsidation of a genome engineering system |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US10870865B2 (ja) |
| EP (1) | EP3455239B1 (ja) |
| JP (1) | JP6982001B2 (ja) |
| CN (1) | CN109415415A (ja) |
| AU (1) | AU2017263137B2 (ja) |
| CA (1) | CA3024376A1 (ja) |
| DK (1) | DK3455239T3 (ja) |
| ES (1) | ES2886919T3 (ja) |
| IL (1) | IL262941B (ja) |
| PT (1) | PT3455239T (ja) |
| SG (1) | SG11201810015YA (ja) |
| WO (1) | WO2017194902A2 (ja) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3294756B1 (fr) * | 2015-05-15 | 2020-12-02 | Flash Therapeutics | Particule rétrovirale comportant au moins deux arn non viraux encapsidés différents |
| AU2019262029A1 (en) * | 2018-05-01 | 2020-11-19 | Wake Forest University Health Sciences | Lentiviral-based vectors and related systems and methods for eukaryotic gene editing |
| CN108504689B (zh) * | 2018-05-29 | 2021-01-29 | 上海本导基因技术有限公司 | 慢病毒载体及其递送外源rna的方法 |
| EP4247951A2 (en) * | 2020-11-19 | 2023-09-27 | Wake Forest University Health Sciences | Vectors, systems and methods for eukaryotic gene editing |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1041152A1 (en) * | 1996-10-17 | 2000-10-04 | Oxford Biomedica (UK) Limited | Retroviral vectors |
| GB0526210D0 (en) | 2005-12-22 | 2006-02-01 | Oxford Biomedica Ltd | Vectors |
| CN108114276A (zh) * | 2007-08-03 | 2018-06-05 | 巴斯德研究院 | 慢病毒基因转移载体及其医学应用 |
| WO2013014537A1 (en) | 2011-07-27 | 2013-01-31 | Vectalys | Virus-based vector compositions useful for transducing eukaryotic cells |
| WO2016049258A2 (en) * | 2014-09-25 | 2016-03-31 | The Broad Institute Inc. | Functional screening with optimized functional crispr-cas systems |
-
2017
- 2017-05-12 JP JP2018559362A patent/JP6982001B2/ja active Active
- 2017-05-12 ES ES17730841T patent/ES2886919T3/es active Active
- 2017-05-12 DK DK17730841.8T patent/DK3455239T3/da active
- 2017-05-12 EP EP17730841.8A patent/EP3455239B1/fr active Active
- 2017-05-12 PT PT177308418T patent/PT3455239T/pt unknown
- 2017-05-12 SG SG11201810015YA patent/SG11201810015YA/en unknown
- 2017-05-12 CN CN201780043702.XA patent/CN109415415A/zh active Pending
- 2017-05-12 WO PCT/FR2017/051164 patent/WO2017194902A2/fr unknown
- 2017-05-12 CA CA3024376A patent/CA3024376A1/fr active Pending
- 2017-05-12 US US16/301,317 patent/US10870865B2/en active Active
- 2017-05-12 AU AU2017263137A patent/AU2017263137B2/en active Active
-
2018
- 2018-11-12 IL IL262941A patent/IL262941B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2019514414A (ja) | 2019-06-06 |
| DK3455239T3 (da) | 2021-07-05 |
| WO2017194902A2 (fr) | 2017-11-16 |
| PT3455239T (pt) | 2021-07-13 |
| IL262941B (en) | 2022-05-01 |
| IL262941A (en) | 2018-12-31 |
| AU2017263137A1 (en) | 2019-01-03 |
| US10870865B2 (en) | 2020-12-22 |
| WO2017194902A3 (fr) | 2018-01-18 |
| EP3455239B1 (fr) | 2021-04-07 |
| CN109415415A (zh) | 2019-03-01 |
| CA3024376A1 (fr) | 2017-11-16 |
| JP6982001B2 (ja) | 2021-12-17 |
| US20200071720A1 (en) | 2020-03-05 |
| EP3455239A2 (fr) | 2019-03-20 |
| AU2017263137B2 (en) | 2021-05-27 |
| ES2886919T3 (es) | 2021-12-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2022006652A (es) | Proteinas de capside modificadas para un suministro mejorado de vectores de parvovirus. | |
| WO2018136396A3 (en) | Crisprs | |
| SG11201810015YA (en) | Particle for the encapsidation of a genome engineering system | |
| MX2019006467A (es) | Composiciones y métodos para mejorar la expresión génica. | |
| MA52645B1 (fr) | Vaccins contre le virus respiratoire | |
| CY1124453T1 (el) | Πολυπεπτιδια που περιεχουν επικρατειες προσδεσης de novo και χρησεις αυτων | |
| PH12019501130A1 (en) | Viral delivery of neoantigens | |
| MX2020011939A (es) | Nuevas enzimas y sistemas crispr. | |
| MX2019002946A (es) | Anticuerpos anti-pd-1 y sus usos. | |
| MX2017010857A (es) | Metodos para la cobertura de secuencia de acidos nucleicos seleccionados como diana. | |
| MX2018005392A (es) | Acidos nucleicos modificados dirigidos a acidos nucleicos. | |
| MX2019004499A (es) | Sistemas de replicón de virus recombinante y usos de estos. | |
| WO2015191693A3 (en) | Method for gene editing | |
| AU2016262093A8 (en) | Enhancing endonuclease based gene editing in primary cells | |
| NZ729012A (en) | Recombinant modified vaccinia virus ankara (mva) filovirus vaccine | |
| WO2017066764A3 (en) | Modification of n-terminal region of capsid proteins for enhanced properties of adeno-associated viruses | |
| AU2015286820A8 (en) | Stabilization of poly(A) sequence encoding DNA sequences | |
| WO2018191502A3 (en) | Anti-cd137 antibodies and methods of use thereof | |
| EA201201025A1 (ru) | Молекулы нуклеиновых кислот гриппа и вакцины, изготовленные из них | |
| WO2009124312A3 (en) | Consensus sequences of chikungunya viral proteins, nucleic acid molecules encoding the same, and compositions and methods for using the same | |
| EA201992232A1 (ru) | Композиции и способы для иммуноонкологии | |
| MX2017008096A (es) | Pestivirus. | |
| WO2018017747A3 (en) | Oncolytic viruses targeting stat3 | |
| MX2017005524A (es) | Metodos y composiciones para el virus del dengue recombinante para el desarrollo de vacunas y de diagnostico. | |
| EA201890351A1 (ru) | Рекомбинантный orf-вирусный вектор |